Armata Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2013 to Q2 2024.
  • Armata Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 58.2M shares, a 3.01% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 36.1M shares, a 5.2% increase from 2022.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 34.3M shares, a 42.3% increase from 2021.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 24.1M shares, a 46.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 58.2M +1.7M +3.01% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 36.1M +79.9K +0.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 36.1M +1.78M +5.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 36.1M +48.3K +0.13% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 56.5M +20.5M +57.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 36M +7.05M +24.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 34.3M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 36M +11.2M +45.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 36M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 29M +8.54M +41.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 24.8M +6.43M +34.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q1 2021 20.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 18.4M +8.84M +92.6% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 18.3M +10.6M +138% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q4 2019 8.01M +3.36M +72.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 9.55M +4.9M +105% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 7.72M +3.07M +65.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 32.4M +19.1M +144% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-06
Q4 2018 4.65M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 4.65M -4.22M -47.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 4.65M -867K -15.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 13.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q3 2017 8.87M +7.76M +698% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 5.52M +4.64M +530% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q4 2016 984K -4.43M -81.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 1.11M -4.7M -80.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 877K -6.67M -88.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 5.88M +1.64M +38.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 5.41M Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 5.81M +26.2K +0.45% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 7.55M +1.64M +27.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 4.25M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 5.79M -93.4M -94.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 5.91M -84.7M -93.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q3 2013 99.2M Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-04-15
Q2 2013 90.6M Apr 1, 2013 Jun 30, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.